logo
  • Home
  • News
Menu

For India’s Pharma Tycoons, Covid-19 Vaccines Are The New Cash Cows

Home / Stock Analysis / For India’s Pharma Tycoons, Covid-19 Vaccines Are The New Cash Cows
Article feature image

For India’s Pharma Tycoons, Covid-19 Vaccines Are The New Cash Cows

31 Jul Stock Analysis

Adar Poonawalla, CEO of Serum Institute of India, at the company’s Hadapsar plant in Pune, …

Click here to view the original article.

Tags:
Forbes, Global
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

1585186858130.jpeg
+

Assessing Snap’s (SNAP) Valuation Following Recent Share Price Weakness

04 Nov Stock Analysis
e53b88b748baf72b2f8ce944fa9b9171.png
+

Revenues to Exceed $14 Billion Spurred by Urbanization and Busy Lifestyles

04 Nov Stock Analysis

recent post

  • 1585186858130.jpeg

    Assessing Snap’s (SNAP) Valuation Following Recent

    Nov 04 2025
  • Chart4_red-gID_7.png

    Crypto Liquidations Top $2 Billion as

    Nov 04 2025
  • bda9f00447cc2b1732d24db766e61caf.jpeg

    Bitcoin Falls Below $100K, Wipes Out

    Nov 04 2025
  • e53b88b748baf72b2f8ce944fa9b9171.png

    Revenues to Exceed $14 Billion Spurred

    Nov 04 2025
  • 39980a370e79fb6757a4592dbc1af759fccf2a32-3840x2160.png

    Falls Below $100K for First Time

    Nov 04 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.